Todos os procedimentos com animais descritos aqui devem ser conduzidos em conformidade com as diretrizes institucionais de ética animal e aprovados pe…
Metodologias de Novas Abordagens, ou NAMs, são estratégias modernas usadas para estudar respostas biológicas enquanto reduzem a dependência de modelos animais vertebrados.
Por exemplo, abordagens computacionais são usadas para analisar a estrutura de um composto de teste, identificar proteínas-alvo relevantes e avaliar interações composto-proteína para prever potenciais efeitos biológicos.
Além disso, métodos não animais, como ensaios baseados em células e sistemas de órgãos-em-chip, são selecionados com base no objetivo da pesquisa. Por exemplo, células podem ser tratadas com um composto de teste para avaliar sua citotoxicidade.
Além disso, diferentes concentrações de um composto de teste podem ser avaliadas em ambientes controlados in vitro para determinar uma concentração eficaz antes de progredir para modelos animais.
Em alguns casos, modelos animais alternativos, como embriões de peixe-zebra ou Drosophila, são usados para refinar ainda mais a seleção de compostos. Por exemplo, os efeitos de um composto de teste no desenvolvimento de embriões de peixe-zebra podem ser avaliados para avaliar a toxicidade.
Juntas, essas abordagens reduzem a dependência de modelos animais vertebrados tradicionais.
View the full transcript and gain access to JoVE Science Education videos
Q1: What are New Approach Methodologies and why are they used in research?
New Approach Methodologies (NAMs) are modern scientific strategies that generate biological data while reducing reliance on traditional vertebrate animal models. NAMs include computational modeling, cell-based assays, organ-on-chip systems, and alternative animal models like zebrafish embryos. These approaches support the 3Rs principle—Replacement, Reduction, and Refinement—enabling researchers to conduct ethical, efficient studies with human-derived cells and tissues.
Q2: How do computational approaches contribute to New Approach Methodologies?
Computational methods analyze test compound structures, identify relevant target proteins, and evaluate compound-protein interactions to predict potential biological effects. These approaches help prioritize compounds for further testing before moving to laboratory studies. By identifying promising candidates early, computational modeling reduces the number of compounds requiring experimental evaluation and supports more efficient research planning.
Q3: What role do cell-based assays play in NAMs?
Cell-based assays are non-animal methods used to evaluate compound effects under controlled in vitro conditions. Cells can be treated with test compounds to assess cytotoxicity, and different concentrations can be tested to determine effective doses before progressing to animal models. These assays provide mechanistic and toxicity-related information while reducing the need for vertebrate animal studies.
Q4: How are alternative animal models used within NAMs?
Alternative animal models such as zebrafish embryos and Drosophila (fruit flies) are used to refine compound selection and evaluate toxicity effects. For example, zebrafish embryo development can be assessed to determine compound safety before testing in traditional vertebrate models. These alternatives provide valuable biological data while supporting the principles of Replacement and Reduction in research.
Q5: What are organ-on-chip systems and how do they support NAMs?
Organ-on-chip systems are advanced in vitro technologies that mimic organ function in controlled laboratory environments. These systems allow researchers to study biological processes and evaluate compound effects with greater physiological relevance than traditional cell cultures. By providing realistic tissue responses, organ-on-chip systems reduce the need for animal testing while generating high-quality biological data.
Q6: How does integrating multiple NAM approaches improve research outcomes?
Integrating data from computational methods, cell-based assays, organ-on-chip systems, and alternative animal models creates a comprehensive evaluation strategy. Computational methods prioritize compounds, in vitro systems provide mechanistic data, and alternative models offer additional safety assessment. This integrated approach identifies promising compounds and potential hazards early, improving study design, reducing animal use, and supporting more efficient research.
Q7: What ethical principles guide the use of NAMs in research?
NAMs are designed to support the 3Rs principle: Replacement (using non-animal methods), Reduction (minimizing animal numbers), and Refinement (improving animal welfare). All animal procedures must comply with institutional ethics guidelines and IACUC approval. By using human-derived cells and tissues and identifying safety concerns early, NAMs help researchers conduct ethical studies that reduce vertebrate animal reliance while maintaining scientific rigor.